APO Research

APO RESEARCH · REPORT

Pseudovirus Neutralization Assay Service

Selected research

Market Analysis & Forecast

Global Pseudovirus Neutralization Assay Service Market Analysis and Forecast 2026-2032

Market perspective

The global Pseudovirus Neutralization Assay Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Pseudovirus Neutralization Assay Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Pseudovirus Neutralization Assay Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Pseudovirus Neutralization Assay Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Pseudovirus Neutralization Assay Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Pseudovirus Neutralization Assay Service include GenScript ProBio, ACROBiosystems, Creative-Diagnostics, eEnzyme, Abnova, Creative-Biogene, Creative Bioarray, Immuno Spot and Creative Diagnostics, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Pseudovirus Neutralization Assay Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Pseudovirus Neutralization Assay Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Pseudovirus Neutralization Assay Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pseudovirus Neutralization Assay Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pseudovirus Neutralization Assay Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Pseudovirus Neutralization Assay Service revenue, projected growth trends, production technology, application and end-user industry.

Pseudovirus Neutralization Assay Service Segment by Company

GenScript ProBio

ACROBiosystems

Creative-Diagnostics

eEnzyme

Abnova

Creative-Biogene

Creative Bioarray

Immuno Spot

Creative Diagnostics

Cellecta

RayBiotech

ACROBiosystems Group

Pseudovirus Neutralization Assay Service Segment by Type

Specific NAb Assay

Anti-SARS-CoV-2 NAb Assay

Pseudovirus Neutralization Assay Service Segment by Application

Hospital

Research Institute

Others

Pseudovirus Neutralization Assay Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pseudovirus Neutralization Assay Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pseudovirus Neutralization Assay Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pseudovirus Neutralization Assay Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Pseudovirus Neutralization Assay Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Pseudovirus Neutralization Assay Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pseudovirus Neutralization Assay Service revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pseudovirus Neutralization Assay Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Specific NAb Assay Major Player Table 3. Anti-SARS-CoV-2 NAb Assay Major Player Table 4. Global Pseudovirus Neutralization Assay Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Player Table 6. Research Institute Major Player Table 7. Others Major Player Table 8. Pseudovirus Neutralization Assay Service Industry Trends Table 9. Pseudovirus Neutralization Assay Service Industry Drivers Table 10. Pseudovirus Neutralization Assay Service Industry Opportunities and Challenges Table 11. Pseudovirus Neutralization Assay Service Industry Restraints Table 12. Global Pseudovirus Neutralization Assay Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Pseudovirus Neutralization Assay Service Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Pseudovirus Neutralization Assay Service Market Share by Region (2021-2026) Table 15. Global Pseudovirus Neutralization Assay Service Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Pseudovirus Neutralization Assay Service Market Share by Region (2027-2032) Table 17. Global Pseudovirus Neutralization Assay Service Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Pseudovirus Neutralization Assay Service Revenue Market Share by Players (2021-2026) Table 19. Global Pseudovirus Neutralization Assay Service Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Pseudovirus Neutralization Assay Service Key Players Headquarters & Area Served Table 21. Global Pseudovirus Neutralization Assay Service Players, Product Type & Application Table 22. Global Pseudovirus Neutralization Assay Service Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Pseudovirus Neutralization Assay Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Pseudovirus Neutralization Assay Service Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Pseudovirus Neutralization Assay Service Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Pseudovirus Neutralization Assay Service Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Pseudovirus Neutralization Assay Service Revenue Market Share by Type (2021-2026) Table 29. Global Pseudovirus Neutralization Assay Service Revenue Market Share by Type (2027-2032) Table 30. Global Pseudovirus Neutralization Assay Service Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Pseudovirus Neutralization Assay Service Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Pseudovirus Neutralization Assay Service Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Pseudovirus Neutralization Assay Service Revenue Market Share by Application (2021-2026) Table 34. Global Pseudovirus Neutralization Assay Service Revenue Market Share by Application (2027-2032) Table 35. GenScript ProBio Company Information Table 36. GenScript ProBio Business Overview Table 37. GenScript ProBio Pseudovirus Neutralization Assay Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. GenScript ProBio Pseudovirus Neutralization Assay Service Product Portfolio Table 39. GenScript ProBio Recent Development Table 40. ACROBiosystems Company Information Table 41. ACROBiosystems Business Overview Table 42. ACROBiosystems Pseudovirus Neutralization Assay Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. ACROBiosystems Pseudovirus Neutralization Assay Service Product Portfolio Table 44. ACROBiosystems Recent Development Table 45. Creative-Diagnostics Company Information Table 46. Creative-Diagnostics Business Overview Table 47. Creative-Diagnostics Pseudovirus Neutralization Assay Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Creative-Diagnostics Pseudovirus Neutralization Assay Service Product Portfolio Table 49. Creative-Diagnostics Recent Development Table 50. eEnzyme Company Information Table 51. eEnzyme Business Overview Table 52. eEnzyme Pseudovirus Neutralization Assay Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. eEnzyme Pseudovirus Neutralization Assay Service Product Portfolio Table 54. eEnzyme Recent Development Table 55. Abnova Company Information Table 56. Abnova Business Overview Table 57. Abnova Pseudovirus Neutralization Assay Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Abnova Pseudovirus Neutralization Assay Service Product Portfolio Table 59. Abnova Recent Development Table 60. Creative-Biogene Company Information Table 61. Creative-Biogene Business Overview Table 62. Creative-Biogene Pseudovirus Neutralization Assay Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Creative-Biogene Pseudovirus Neutralization Assay Service Product Portfolio Table 64. Creative-Biogene Recent Development Table 65. Creative Bioarray Company Information Table 66. Creative Bioarray Business Overview Table 67. Creative Bioarray Pseudovirus Neutralization Assay Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Creative Bioarray Pseudovirus Neutralization Assay Service Product Portfolio Table 69. Creative Bioarray Recent Development Table 70. Immuno Spot Company Information Table 71. Immuno Spot Business Overview Table 72. Immuno Spot Pseudovirus Neutralization Assay Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Immuno Spot Pseudovirus Neutralization Assay Service Product Portfolio Table 74. Immuno Spot Recent Development Table 75. Creative Diagnostics Company Information Table 76. Creative Diagnostics Business Overview Table 77. Creative Diagnostics Pseudovirus Neutralization Assay Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Creative Diagnostics Pseudovirus Neutralization Assay Service Product Portfolio Table 79. Creative Diagnostics Recent Development Table 80. Cellecta Company Information Table 81. Cellecta Business Overview Table 82. Cellecta Pseudovirus Neutralization Assay Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Cellecta Pseudovirus Neutralization Assay Service Product Portfolio Table 84. Cellecta Recent Development Table 85. RayBiotech Company Information Table 86. RayBiotech Business Overview Table 87. RayBiotech Pseudovirus Neutralization Assay Service Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. RayBiotech Pseudovirus Neutralization Assay Service Product Portfolio Table 89. RayBiotech Recent Development Table 90. ACROBiosystems Group Company Information Table 91. ACROBiosystems Group Business Overview Table 92. ACROBiosystems Group Pseudovirus Neutralization Assay Service Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. ACROBiosystems Group Pseudovirus Neutralization Assay Service Product Portfolio Table 94. ACROBiosystems Group Recent Development Table 95. North America Pseudovirus Neutralization Assay Service Revenue by Type (2021-2026) & (US$ Million) Table 96. North America Pseudovirus Neutralization Assay Service Revenue by Type (2027-2032) & (US$ Million) Table 97. North America Pseudovirus Neutralization Assay Service Revenue by Application (2021-2026) & (US$ Million) Table 98. North America Pseudovirus Neutralization Assay Service Revenue by Application (2027-2032) & (US$ Million) Table 99. North America Pseudovirus Neutralization Assay Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 100. North America Pseudovirus Neutralization Assay Service Revenue by Country (2021-2026) & (US$ Million) Table 101. North America Pseudovirus Neutralization Assay Service Revenue by Country (US$ Million) & (2027-2032) Table 102. Europe Pseudovirus Neutralization Assay Service Revenue by Type (2021-2026) & (US$ Million) Table 103. Europe Pseudovirus Neutralization Assay Service Revenue by Type (2027-2032) & (US$ Million) Table 104. Europe Pseudovirus Neutralization Assay Service Revenue by Application (2021-2026) & (US$ Million) Table 105. Europe Pseudovirus Neutralization Assay Service Revenue by Application (2027-2032) & (US$ Million) Table 106. Europe Pseudovirus Neutralization Assay Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 107. Europe Pseudovirus Neutralization Assay Service Revenue by Country (2021-2026) & (US$ Million) Table 108. Europe Pseudovirus Neutralization Assay Service Revenue by Country (US$ Million) & (2027-2032) Table 109. China Pseudovirus Neutralization Assay Service Revenue by Type (2021-2026) & (US$ Million) Table 110. China Pseudovirus Neutralization Assay Service Revenue by Type (2027-2032) & (US$ Million) Table 111. China Pseudovirus Neutralization Assay Service Revenue by Application (2021-2026) & (US$ Million) Table 112. China Pseudovirus Neutralization Assay Service Revenue by Application (2027-2032) & (US$ Million) Table 113. Asia Pseudovirus Neutralization Assay Service Revenue by Type (2021-2026) & (US$ Million) Table 114. Asia Pseudovirus Neutralization Assay Service Revenue by Type (2027-2032) & (US$ Million) Table 115. Asia Pseudovirus Neutralization Assay Service Revenue by Application (2021-2026) & (US$ Million) Table 116. Asia Pseudovirus Neutralization Assay Service Revenue by Application (2027-2032) & (US$ Million) Table 117. Asia Pseudovirus Neutralization Assay Service Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 118. Asia Pseudovirus Neutralization Assay Service Revenue by Region (US$ Million) & (2021-2026) Table 119. Asia Pseudovirus Neutralization Assay Service Revenue by Region (US$ Million) & (2027-2032) Table 120. SAMEA Pseudovirus Neutralization Assay Service Revenue by Type (2021-2026) & (US$ Million) Table 121. SAMEA Pseudovirus Neutralization Assay Service Revenue by Type (2027-2032) & (US$ Million) Table 122. SAMEA Pseudovirus Neutralization Assay Service Revenue by Application (2021-2026) & (US$ Million) Table 123. SAMEA Pseudovirus Neutralization Assay Service Revenue by Application (2027-2032) & (US$ Million) Table 124. SAMEA Pseudovirus Neutralization Assay Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 125. SAMEA Pseudovirus Neutralization Assay Service Revenue by Country (2021-2026) & (US$ Million) Table 126. SAMEA Pseudovirus Neutralization Assay Service Revenue by Country (US$ Million) & (2027-2032) Table 127. Research Programs/Design for This Report Table 128. Authors List of This Report Table 129. Secondary Sources Table 130. Primary Sources List of Figures Figure 1. Pseudovirus Neutralization Assay Service Image Figure 2. Global Pseudovirus Neutralization Assay Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pseudovirus Neutralization Assay Service Market Size Share 2021 VS 2025 VS 2032 Figure 4. Specific NAb Assay Image Figure 5. Anti-SARS-CoV-2 NAb Assay Image Figure 6. Global Pseudovirus Neutralization Assay Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Pseudovirus Neutralization Assay Service Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Research Institute Image Figure 10. Others Image Figure 11. Global Pseudovirus Neutralization Assay Service Market Size (US$ Million) & (2021-2032) Figure 12. Global Pseudovirus Neutralization Assay Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Pseudovirus Neutralization Assay Service Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Pseudovirus Neutralization Assay Service Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Pseudovirus Neutralization Assay Service Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Pseudovirus Neutralization Assay Service Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Pseudovirus Neutralization Assay Service Revenue Market Share by Type (2021-2032) Figure 19. Global Pseudovirus Neutralization Assay Service Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Pseudovirus Neutralization Assay Service Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Pseudovirus Neutralization Assay Service Revenue Market Share by Application (2021-2032) Figure 22. North America Pseudovirus Neutralization Assay Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Pseudovirus Neutralization Assay Service Revenue Share by Type (2021-2032) Figure 24. North America Pseudovirus Neutralization Assay Service Revenue Share by Application (2021-2032) Figure 25. North America Pseudovirus Neutralization Assay Service Revenue Share by Country (2021-2032) Figure 26. United States Pseudovirus Neutralization Assay Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Pseudovirus Neutralization Assay Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Pseudovirus Neutralization Assay Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Pseudovirus Neutralization Assay Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Pseudovirus Neutralization Assay Service Revenue Share by Type (2021-2032) Figure 31. Europe Pseudovirus Neutralization Assay Service Revenue Share by Application (2021-2032) Figure 32. Europe Pseudovirus Neutralization Assay Service Revenue Share by Country (2021-2032) Figure 33. Germany Pseudovirus Neutralization Assay Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Pseudovirus Neutralization Assay Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Pseudovirus Neutralization Assay Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Pseudovirus Neutralization Assay Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Pseudovirus Neutralization Assay Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Pseudovirus Neutralization Assay Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Pseudovirus Neutralization Assay Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Pseudovirus Neutralization Assay Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Pseudovirus Neutralization Assay Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Pseudovirus Neutralization Assay Service Revenue Share by Type (2021-2032) Figure 43. China Pseudovirus Neutralization Assay Service Revenue Share by Application (2021-2032) Figure 44. Asia Pseudovirus Neutralization Assay Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Pseudovirus Neutralization Assay Service Revenue Share by Type (2021-2032) Figure 46. Asia Pseudovirus Neutralization Assay Service Revenue Share by Application (2021-2032) Figure 47. Asia Pseudovirus Neutralization Assay Service Revenue Share by Region (2021-2032) Figure 48. Japan Pseudovirus Neutralization Assay Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Pseudovirus Neutralization Assay Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Pseudovirus Neutralization Assay Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Pseudovirus Neutralization Assay Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Pseudovirus Neutralization Assay Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Pseudovirus Neutralization Assay Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Pseudovirus Neutralization Assay Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Pseudovirus Neutralization Assay Service Revenue Share by Type (2021-2032) Figure 56. SAMEA Pseudovirus Neutralization Assay Service Revenue Share by Application (2021-2032) Figure 57. SAMEA Pseudovirus Neutralization Assay Service Revenue Share by Country (2021-2032) Figure 58. Brazil Pseudovirus Neutralization Assay Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Pseudovirus Neutralization Assay Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Pseudovirus Neutralization Assay Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Pseudovirus Neutralization Assay Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Pseudovirus Neutralization Assay Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Pseudovirus Neutralization Assay Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Pseudovirus Neutralization Assay Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Pseudovirus Neutralization Assay Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Pseudovirus Neutralization Assay Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Pseudovirus Neutralization Assay Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Pseudovirus Neutralization Assay Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Specific NAb Assay
  • Anti-SARS-CoV-2 NAb Assay
Applications
  • Hospital
  • Research Institute
  • Others
Companies covered
  • GenScript ProBio
  • ACROBiosystems
  • Creative-Diagnostics
  • eEnzyme
  • Abnova
  • Creative-Biogene
  • Creative Bioarray
  • Immuno Spot
  • Creative Diagnostics
  • Cellecta
  • RayBiotech
  • ACROBiosystems Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Pseudovirus Neutralization Assay Service Market by Type
  3. 1.2.1 Global Pseudovirus Neutralization Assay Service Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Specific NAb Assay
  5. 1.2.3 Anti-SARS-CoV-2 NAb Assay
  6. 1.3 Pseudovirus Neutralization Assay Service Market by Application
  7. 1.3.1 Global Pseudovirus Neutralization Assay Service Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Research Institute
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Pseudovirus Neutralization Assay Service Market Dynamics
  1. 2.1 Pseudovirus Neutralization Assay Service Industry Trends
  2. 2.2 Pseudovirus Neutralization Assay Service Industry Drivers
  3. 2.3 Pseudovirus Neutralization Assay Service Industry Opportunities and Challenges
  4. 2.4 Pseudovirus Neutralization Assay Service Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Pseudovirus Neutralization Assay Service Market Perspective (2021-2032)
  2. 3.2 Global Pseudovirus Neutralization Assay Service Growth Trends by Region
  3. 3.2.1 Global Pseudovirus Neutralization Assay Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Pseudovirus Neutralization Assay Service Market Size by Region (2021-2026)
  5. 3.2.3 Global Pseudovirus Neutralization Assay Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Pseudovirus Neutralization Assay Service Revenue by Players
  2. 4.1.1 Global Pseudovirus Neutralization Assay Service Revenue by Players (2021-2026)
  3. 4.1.2 Global Pseudovirus Neutralization Assay Service Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Pseudovirus Neutralization Assay Service Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Pseudovirus Neutralization Assay Service Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Pseudovirus Neutralization Assay Service Key Players Headquarters & Area Served
  7. 4.4 Global Pseudovirus Neutralization Assay Service Players, Product Type & Application
  8. 4.5 Global Pseudovirus Neutralization Assay Service Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Pseudovirus Neutralization Assay Service Market CR5 and HHI
  11. 4.6.3 2025 Pseudovirus Neutralization Assay Service Tier 1, Tier 2, and Tier 3
5 Pseudovirus Neutralization Assay Service Market Size by Type
  1. 5.1 Global Pseudovirus Neutralization Assay Service Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Pseudovirus Neutralization Assay Service Revenue by Type (2021-2032)
  3. 5.3 Global Pseudovirus Neutralization Assay Service Revenue Market Share by Type (2021-2032)
6 Pseudovirus Neutralization Assay Service Market Size by Application
  1. 6.1 Global Pseudovirus Neutralization Assay Service Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Pseudovirus Neutralization Assay Service Revenue by Application (2021-2032)
  3. 6.3 Global Pseudovirus Neutralization Assay Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 GenScript ProBio
  2. 7.1.1 GenScript ProBio Company Information
  3. 7.1.2 GenScript ProBio Business Overview
  4. 7.1.3 GenScript ProBio Pseudovirus Neutralization Assay Service Revenue and Gross Margin (2021-2026)
  5. 7.1.4 GenScript ProBio Pseudovirus Neutralization Assay Service Product Portfolio
  6. 7.1.5 GenScript ProBio Recent Developments
  7. 7.2 ACROBiosystems
  8. 7.2.1 ACROBiosystems Company Information
  9. 7.2.2 ACROBiosystems Business Overview
  10. 7.2.3 ACROBiosystems Pseudovirus Neutralization Assay Service Revenue and Gross Margin (2021-2026)
  11. 7.2.4 ACROBiosystems Pseudovirus Neutralization Assay Service Product Portfolio
  12. 7.2.5 ACROBiosystems Recent Developments
  13. 7.3 Creative-Diagnostics
  14. 7.3.1 Creative-Diagnostics Company Information
  15. 7.3.2 Creative-Diagnostics Business Overview
  16. 7.3.3 Creative-Diagnostics Pseudovirus Neutralization Assay Service Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Creative-Diagnostics Pseudovirus Neutralization Assay Service Product Portfolio
  18. 7.3.5 Creative-Diagnostics Recent Developments
  19. 7.4 eEnzyme
  20. 7.4.1 eEnzyme Company Information
  21. 7.4.2 eEnzyme Business Overview
  22. 7.4.3 eEnzyme Pseudovirus Neutralization Assay Service Revenue and Gross Margin (2021-2026)
  23. 7.4.4 eEnzyme Pseudovirus Neutralization Assay Service Product Portfolio
  24. 7.4.5 eEnzyme Recent Developments
  25. 7.5 Abnova
  26. 7.5.1 Abnova Company Information
  27. 7.5.2 Abnova Business Overview
  28. 7.5.3 Abnova Pseudovirus Neutralization Assay Service Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Abnova Pseudovirus Neutralization Assay Service Product Portfolio
  30. 7.5.5 Abnova Recent Developments
  31. 7.6 Creative-Biogene
  32. 7.6.1 Creative-Biogene Company Information
  33. 7.6.2 Creative-Biogene Business Overview
  34. 7.6.3 Creative-Biogene Pseudovirus Neutralization Assay Service Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Creative-Biogene Pseudovirus Neutralization Assay Service Product Portfolio
  36. 7.6.5 Creative-Biogene Recent Developments
  37. 7.7 Creative Bioarray
  38. 7.7.1 Creative Bioarray Company Information
  39. 7.7.2 Creative Bioarray Business Overview
  40. 7.7.3 Creative Bioarray Pseudovirus Neutralization Assay Service Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Creative Bioarray Pseudovirus Neutralization Assay Service Product Portfolio
  42. 7.7.5 Creative Bioarray Recent Developments
  43. 7.8 Immuno Spot
  44. 7.8.1 Immuno Spot Company Information
  45. 7.8.2 Immuno Spot Business Overview
  46. 7.8.3 Immuno Spot Pseudovirus Neutralization Assay Service Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Immuno Spot Pseudovirus Neutralization Assay Service Product Portfolio
  48. 7.8.5 Immuno Spot Recent Developments
  49. 7.9 Creative Diagnostics
  50. 7.9.1 Creative Diagnostics Company Information
  51. 7.9.2 Creative Diagnostics Business Overview
  52. 7.9.3 Creative Diagnostics Pseudovirus Neutralization Assay Service Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Creative Diagnostics Pseudovirus Neutralization Assay Service Product Portfolio
  54. 7.9.5 Creative Diagnostics Recent Developments
  55. 7.10 Cellecta
  56. 7.10.1 Cellecta Company Information
  57. 7.10.2 Cellecta Business Overview
  58. 7.10.3 Cellecta Pseudovirus Neutralization Assay Service Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Cellecta Pseudovirus Neutralization Assay Service Product Portfolio
  60. 7.10.5 Cellecta Recent Developments
  61. 7.11 RayBiotech
  62. 7.11.1 RayBiotech Company Information
  63. 7.11.2 RayBiotech Business Overview
  64. 7.11.3 RayBiotech Pseudovirus Neutralization Assay Service Revenue and Gross Margin (2021-2026)
  65. 7.11.4 RayBiotech Pseudovirus Neutralization Assay Service Product Portfolio
  66. 7.11.5 RayBiotech Recent Developments
  67. 7.12 ACROBiosystems Group
  68. 7.12.1 ACROBiosystems Group Company Information
  69. 7.12.2 ACROBiosystems Group Business Overview
  70. 7.12.3 ACROBiosystems Group Pseudovirus Neutralization Assay Service Revenue and Gross Margin (2021-2026)
  71. 7.12.4 ACROBiosystems Group Pseudovirus Neutralization Assay Service Product Portfolio
  72. 7.12.5 ACROBiosystems Group Recent Developments
8 North America
  1. 8.1 North America Pseudovirus Neutralization Assay Service Revenue (2021-2032)
  2. 8.2 North America Pseudovirus Neutralization Assay Service Revenue by Type (2021-2032)
  3. 8.2.1 North America Pseudovirus Neutralization Assay Service Revenue by Type (2021-2026)
  4. 8.2.2 North America Pseudovirus Neutralization Assay Service Revenue by Type (2027-2032)
  5. 8.3 North America Pseudovirus Neutralization Assay Service Revenue Share by Type (2021-2032)
  6. 8.4 North America Pseudovirus Neutralization Assay Service Revenue by Application (2021-2032)
  7. 8.4.1 North America Pseudovirus Neutralization Assay Service Revenue by Application (2021-2026)
  8. 8.4.2 North America Pseudovirus Neutralization Assay Service Revenue by Application (2027-2032)
  9. 8.5 North America Pseudovirus Neutralization Assay Service Revenue Share by Application (2021-2032)
  10. 8.6 North America Pseudovirus Neutralization Assay Service Revenue by Country
  11. 8.6.1 North America Pseudovirus Neutralization Assay Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Pseudovirus Neutralization Assay Service Revenue by Country (2021-2026)
  13. 8.6.3 North America Pseudovirus Neutralization Assay Service Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Pseudovirus Neutralization Assay Service Revenue (2021-2032)
  2. 9.2 Europe Pseudovirus Neutralization Assay Service Revenue by Type (2021-2032)
  3. 9.2.1 Europe Pseudovirus Neutralization Assay Service Revenue by Type (2021-2026)
  4. 9.2.2 Europe Pseudovirus Neutralization Assay Service Revenue by Type (2027-2032)
  5. 9.3 Europe Pseudovirus Neutralization Assay Service Revenue Share by Type (2021-2032)
  6. 9.4 Europe Pseudovirus Neutralization Assay Service Revenue by Application (2021-2032)
  7. 9.4.1 Europe Pseudovirus Neutralization Assay Service Revenue by Application (2021-2026)
  8. 9.4.2 Europe Pseudovirus Neutralization Assay Service Revenue by Application (2027-2032)
  9. 9.5 Europe Pseudovirus Neutralization Assay Service Revenue Share by Application (2021-2032)
  10. 9.6 Europe Pseudovirus Neutralization Assay Service Revenue by Country
  11. 9.6.1 Europe Pseudovirus Neutralization Assay Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Pseudovirus Neutralization Assay Service Revenue by Country (2021-2026)
  13. 9.6.3 Europe Pseudovirus Neutralization Assay Service Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Pseudovirus Neutralization Assay Service Revenue (2021-2032)
  2. 10.2 China Pseudovirus Neutralization Assay Service Revenue by Type (2021-2032)
  3. 10.2.1 China Pseudovirus Neutralization Assay Service Revenue by Type (2021-2026)
  4. 10.2.2 China Pseudovirus Neutralization Assay Service Revenue by Type (2027-2032)
  5. 10.3 China Pseudovirus Neutralization Assay Service Revenue Share by Type (2021-2032)
  6. 10.4 China Pseudovirus Neutralization Assay Service Revenue by Application (2021-2032)
  7. 10.4.1 China Pseudovirus Neutralization Assay Service Revenue by Application (2021-2026)
  8. 10.4.2 China Pseudovirus Neutralization Assay Service Revenue by Application (2027-2032)
  9. 10.5 China Pseudovirus Neutralization Assay Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Pseudovirus Neutralization Assay Service Revenue (2021-2032)
  2. 11.2 Asia Pseudovirus Neutralization Assay Service Revenue by Type (2021-2032)
  3. 11.2.1 Asia Pseudovirus Neutralization Assay Service Revenue by Type (2021-2026)
  4. 11.2.2 Asia Pseudovirus Neutralization Assay Service Revenue by Type (2027-2032)
  5. 11.3 Asia Pseudovirus Neutralization Assay Service Revenue Share by Type (2021-2032)
  6. 11.4 Asia Pseudovirus Neutralization Assay Service Revenue by Application (2021-2032)
  7. 11.4.1 Asia Pseudovirus Neutralization Assay Service Revenue by Application (2021-2026)
  8. 11.4.2 Asia Pseudovirus Neutralization Assay Service Revenue by Application (2027-2032)
  9. 11.5 Asia Pseudovirus Neutralization Assay Service Revenue Share by Application (2021-2032)
  10. 11.6 Asia Pseudovirus Neutralization Assay Service Revenue by Country
  11. 11.6.1 Asia Pseudovirus Neutralization Assay Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Pseudovirus Neutralization Assay Service Revenue by Country (2021-2026)
  13. 11.6.3 Asia Pseudovirus Neutralization Assay Service Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Pseudovirus Neutralization Assay Service Revenue (2021-2032)
  2. 12.2 SAMEA Pseudovirus Neutralization Assay Service Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Pseudovirus Neutralization Assay Service Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Pseudovirus Neutralization Assay Service Revenue by Type (2027-2032)
  5. 12.3 SAMEA Pseudovirus Neutralization Assay Service Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Pseudovirus Neutralization Assay Service Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Pseudovirus Neutralization Assay Service Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Pseudovirus Neutralization Assay Service Revenue by Application (2027-2032)
  9. 12.5 SAMEA Pseudovirus Neutralization Assay Service Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Pseudovirus Neutralization Assay Service Revenue by Country
  11. 12.6.1 SAMEA Pseudovirus Neutralization Assay Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Pseudovirus Neutralization Assay Service Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Pseudovirus Neutralization Assay Service Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research